Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts
Status:
Recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of the drug nitazoxanide 500
mg, administered three times a day, in relation to placebo in preventing the development of
COVID-19 in household contacts of patients diagnosed with the disease.
Phase:
Phase 4
Details
Lead Sponsor:
Fundación Huésped
Collaborators:
Laboratorios Roemmers S.A.I.C.F. Ministerio de Salud de Ciudad Autónoma de Buenos Aires